Next |
home / stock / qure / qure message board
Subject | By | Source | When |
---|---|---|---|
Looks pretty positive | Thoro | investorshub | 06/20/2023 7:20:20 AM |
Do we have a winner?Turn around time? | Thoro | investorshub | 06/17/2023 8:50:17 AM |
$QURE Price gaining last trade up | Panzer | investorshub | 06/16/2023 8:49:55 PM |
and the shorts continue | Panzer | investorshub | 06/16/2023 2:50:25 AM |
$QURE MomentumIts trading up | Panzer | investorshub | 06/13/2023 1:23:30 AM |
Time for this to show some returns | redsox17 | investorshub | 06/12/2023 3:13:26 AM |
just the news we needed | Ch@rter | investorshub | 06/11/2023 3:47:21 AM |
must see | Glider549 | investorshub | 06/08/2023 2:56:33 AM |
$QURE short data if anyone is interested | Panzer | investorshub | 06/06/2023 8:55:44 PM |
The gaining up | Panzer | investorshub | 06/06/2023 8:39:05 PM |
is it bear time? Or do we go bull? | jaytea | investorshub | 06/06/2023 5:50:23 AM |
Good news recently, we should start to see this one move | jaytea | investorshub | 06/04/2023 4:42:00 PM |
$QURE MomentumIts gaining | redsox17 | investorshub | 06/02/2023 8:12:55 PM |
$QURE good read | jaytea | investorshub | 06/01/2023 10:15:37 AM |
$QURE here we go bulls news is here | chmcnfunds | investorshub | 06/01/2023 7:21:33 AM |
When is this gonna take off? | redsox17 | investorshub | 05/31/2023 6:17:10 AM |
$QURE Found an interesting article | chmcnfunds | investorshub | 05/29/2023 2:07:08 AM |
$QURE MomentumIts gaining | Panzer | investorshub | 05/29/2023 1:06:58 AM |
Price trading | redsox17 | investorshub | 05/27/2023 11:55:30 PM |
The gaining up | chmcnfunds | investorshub | 05/27/2023 7:47:32 PM |
News, Short Squeeze, Breakout and More Instantly...
uniQure N.V. Company Name:
QURE Stock Symbol:
NASDAQ Market:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter fin...
~ Presented promising clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington's disease; Up to three years of follo...